Sprint Bioscience AB (5JA1) Income Statement
Sprint Bioscience AB Income Statement
Last quarter (Q2 2026), Sprint Bioscience AB's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Sprint Bioscience AB's net income was $-16.21M. See Sprint Bioscience AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 167.17M | $ 65.64M | $ 50.48M | $ 83.00K | $ 35.11M | |
| $ 97.33M | $ 37.30M | $ 41.79M | $ -60.91M | $ 24.68M | |
| $ 56.54M | $ 56.97M | $ 42.63M | $ 47.32M | $ 50.14M | |
| Depreciation and Amortization | $ 1.07M | $ 958.00K | $ 447.00K | $ 618.00K | $ 590.00K |
| $ 98.40M | $ -17.32M | $ 396.00K | $ -60.00M | $ -24.49M | |
| $ 97.33M | $ -19.67M | $ -845.00K | $ -60.91M | $ -25.47M | |
| $ -5.59M | $ 1.39M | $ 407.00K | $ 739.00K | $ 383.00K | |
| $ 91.74M | $ -18.28M | $ -438.00K | $ -60.17M | $ -25.08M | |
| $ 91.74M | $ -18.28M | $ -438.00K | $ -60.17M | $ -25.35M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.99 | $ -0.26 | $ -0.01 | $ -1.43 | $ -0.73 |
| Diluted EPS | $ 0.99 | $ -0.26 | $ -0.01 | $ -1.43 | $ -0.73 |
| Weighted Average Shares Outstanding | 92.61M | 69.82M | 69.81M | 42.06M | 34.65M |
| Weighted Average Shares Outstanding (Diluted) | 92.61M | 69.82M | 69.81M | 42.06M | 34.65M |
Currency in SEK